Hellman Jordan Management Company’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Other funds holding RETA
CI
Hellman Jordan Management Company's RETA Position: Q4 2021 in Review
Hellman Jordan Management Company sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q4 2021, closing a stake of 6,708 shares — an estimated $675K sold.
Hellman Jordan Management Company first reported a position in RETA in Q1 2021 and held it in 3 quarters. The position peaked at $675K in Q3 2021. 151 funds tracked by Wall St. Rank hold RETA as of Q4 2021.
- Hellman Jordan Management Company reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
- Hellman Jordan Management Company sold 6,708 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q4 2021, an estimated $675K.
- Hellman Jordan Management Company first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2021 and held it in 3 quarters.
- Hellman Jordan Management Company's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $675K in Q3 2021.
- 151 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q4 2021.
Based on Hellman Jordan Management Company's 13F filing for Q4 2021, filed 26 Jan 2022.